The diagnosis, course, and therapeutic management of the benzodiazepine withdrawal syndrome is still a debated question. The correct method for clinical trials in this indication is also not yet codified. A large sample of patients is required, so the trial must be conducted on a multicenter basis. The present paper describes the main features of a protocol aimed at investigating the ability of a new nonbenzodiazepine anxiolytic drug, alpidem, in preventing or treating the benzodiazepine withdrawal syndrome. A pretrial to standardize the diagnostic and evaluation criteria to be used in the multicenter trial is described.
PetraccaAMicheliniSPerugiGCassanoGB. La sindrome da astinenza da benzodiazepine. Problemi di diagnosi differenziale con depressione, attacchi di panico e ansia generalizzata. Clin Ter.1991;137: 191–197.
14.
LaderM.Benzodiazepine withdrawal states. In: TrimbleMR, ed. Benzodiazepine Divided.New York: John Wiley, 1983: 17–31.
15.
APA Task Force.Benzodiazepine Dependence Toxicity and Abuse.Washington: The American Psychiatric Association; 1990.
NoyesRGarveyRJCookBLPerryPJ. Benzodiazepine withdrawal: A review of evidence. J Clin Psychiatry.1988;49: 382–389.
18.
AshtonH.BD withdrawal an unfinished story. Br Med J.1984;288: 1135–1140.
19.
MorselliPL. On the therapeutic action of alpidem in anxiety disorders: An overview of the European data. Pharmacopsychiatry.1990;23(III):129–134.
20.
DimsdaleMFriedmannJCMorselliPLZivkovicP.Alpidem. Drugs of the future.1988;13(2):106–109.
21.
Roy-ByrnePPHommerD.A benzodiazepine withdrawal: Overview and implication for the treatment of anxiety. Am J Med.1988;84: 1041–1052.
22.
LucchelliPEBorghiCFuccellaLM, eds. Multicenter Clinical Trials. Report of the Working Parties on Multicenter Clinical Trials.Milan: Società di Scienze Farmacologiche Applicate (SSFA); 1990.
23.
LaderMOlajideD.A comparison of buspirone and placebo in relieving BD withdrawal symptoms. J Clin Psychopharmacol.1987;7: 11–16.
24.
RickelsKFoxICGreenblattDJ. Clorazepate and lorazepam: Clinical improvement and rebound anxiety. Am J Psychiatry.1988;145: 312–317.
25.
CGI In: GuyW, ed. ECDEU Assessment Manual for Psychopharmacology.Rockville, MD: U.S. Department of Health, Education and Welfare, 1976: 217.
26.
BaiterMBManheimerDIMellingerGDA cross-national comparison of antianxiety/sedative drug use. Curr Med Res Opin.1984;8: 5–20.
27.
PowerKGJerronDWASimpsonRJMitchelM.Controlled study of withdrawal symptoms and rebound anxiety after six week course of diazepam for generalized anxiety. Br Med J Clin Res.1985;290(6477):1246–1248.
28.
FleissJL. Statistical Methods for Rates and Proportions, ed. 2. New York: Wiley & Sons; 1981.
29.
ArmitagePBerryG.Statistical Methods in Medical Research, ed. 2. Oxford, UK: Blackwell Scientific Publications; 1987.
30.
DunnG.Design and Analysis of Reliability Studies. New York: Oxford University Press; 1989.
31.
CesanaBBochicchioDPolliE.Agreement Assessment in Multicenter Clinical Trials. Abstract book of the Joint Meeting of the International Society for Clinical Biostatistics and the Society for Clinical Trials, Bruxelles, Belgium, July 8–12, 1991.
